Aphria Stock: The Merger Deal and its Effects
In December 2020, Aphria and Tilray announced their reverse merger deal whereby it was confirmed that after these two firms will merge, they will form the largest cannabis company in the industry. For once, this announcement boosted the stocks of both companies because it came up as good news. Afterward, the stock of Aphria went down. The value of the stock has thereafter reduced a little. Reason for this Downfall Not all investors are happy with the news of this merger. While the stock of Aphria went down, on one hand, the stock of Tilray went up on the other. The reason for the rise in the stock value of Tilray is that its shareholders will get paid a premium because of this merger deal. If we consider overall, then Aphria has proved to be a more stable and constant company instead of Tilray. Tilray suffered losses this year but Aphria is way too solid for that matter. The investors are mainly concerned about the deal because it could also make things worse rather than making the companies stronger. Stock Analysis: Aphria Inc. (NASDAQ: APHA) and Tilray Inc. (NASDAQ: TLRY) Aphria Inc. (NASDAQ: APHA) 52 Week Range: $1.95 - $8.88 Average Volume: 11,420,290 Market Capital: $1.997B Forward Dividend and Yield: N/A (N/A) Tilray Inc. (NASDAQ: TLRY) 52 Week Range: $2.43 - $22.95 Average Volume: 19,919,441 Market Capital: $1.307B Forward Dividend and Yield: N/A (N/A) The Fate of the Stock of Aphria Inc. (NASDAQ: APHA) Despite the recent downs that the…
